DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2

Cell

Volumn 79, Issue 2, 1994, Pages 329-339

  Strasser, Andreas ^a   Harris, Alan W ^a   Jacks, Tyler ^b   Cory, Suzanne ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

CD4 ANTIGEN; CD8 ANTIGEN; DEXAMETHASONE; DNA; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; ETIOLOGY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; IRRADIATION; LYMPHOMA CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; RADIOSENSITIVITY; T LYMPHOCYTE; THYMOCYTE;

EID: 0028072523     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(94)90201-1     Document Type: Article

References (72)

1. bcl-x a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
2. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
3. Bcl-2 blocks p53-dependent apoptosis
4. Thymocyte apoptosis induced by p53-dependent and independent pathways
5. p53 dependence of early apoptotic and proliferative responses within the mouse intestinal epithelium following γ-irradiation
6. Apoptosis and programmed cell death in immunity
7. pac gene as efficient dominant marker and reporter gene in mammalian cells
8. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells
9. p53 functions as a cell cycle control protein in osteosarcomas
10. The tumor suppressor p53
11. Mice deficient for p53 are developmentally normal but are susceptible to spontaneous tumours
12. Kinetics of mature T cell development in the thymus
13. Mechanisms and functions of cell death
14. bcl-2 modulation of apoptosis induced by anticancer drugs resistance to thymidylate stress is independent of classical resistance pathways
15. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents
16. Quantitative assay for mutation in diploid human lymphoblasts using microtiter plates
17. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays
18. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow
19. Checkpoints controls that ensure the order of cell cycle events
20. C elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
21. The natural history of initially untreated low-grade non-Hodgkin's lymphomas
22. Braking the cycle
23. Expression of bcl-2 in small cell lung carcinoma cells
24. Tumor spectrum analysis in p53-mutant mice
25. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin
26. bcl-2 protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II-induced DNA strand breaks and their repair
27. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
28. Bcl-2 initiates a new category of oncogenes regulators of cell death
29. Wild-type p53 is a cell cycle checkpoint determinant following irradiation
30. H rearrangements in benign lymphoid tissues with follicular hyperplasia
31. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
32. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents
33. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
34. p53 is required for radiation-induced apoptosis in mouse thymocytes
35. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells
36. Effect of bcl-2 on ionizing radiation and 1-β-d-arabinofuranosylcytosine-induced internucleosomal DNA fragmentation and cell survival in human myeloid leukemia cells
37. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein
38. Regulation of apoptosis in transgenic mice by simian virus 40 T antigen-mediated inactivation of p53
39. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14; 18)
40. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice
41. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53
42. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme a mammalian homolog of the C elegans cell death gene ced-3
43. bcl-2 gene transfer increases relative resistance of S491 and WEHI72 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs
44. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
45. Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells
46. Expression of the bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translocation
47. bcl-2 protein in non-small-cell lung carcinoma
48. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest
49. Tumour incidence spectrum and ploidy in mice with a large deletion in the p53 gene
50. Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53
51. Differential expression of bcl-2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin
52. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells
53. T cell development in the adult murine thymus changes in the expression of the surface antigens Ly2 L3T4 and B2A2 during development from early precursor cells to emigrants
54. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes
55. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
56. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line
57. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice
58. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship
59. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease
60. Eμ-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells
61. A rapid single step staining technique for DNA analysis by flow microfluorimetry
62. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
63. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2
64. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line
65. Cell cycle checkpoints, genetic instability and cancer
66. The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae
67. Cell death the significance of apoptosis
68. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
69. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
70. The C elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
71. A comparison of the biological activities of wild-type and mutant p53
72. Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms